SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Oliver & Co who wrote (4817)7/7/1998 11:19:00 PM
From: Izzy   of 6136
 
Dr. Oliver: Thanks for the post (it's great hearing from you again, altho' I realize it is difficult to practice/discuss telemedicine via the 'net). At this time, I'm not willing to abandon HAART (with Viracept). Major issues, not often mentioned, are the medical need for prophylactic/preventive/therapeutic drugs besides HAART and an indication of the patient's clinical status at the time of treatment (eg., asymptomatic HIV, symptomatic HIV, AIDS, AIDS with complications, etc.). From what you know so far, would you be willing, if available, to add Remune to your treatment regimens? I think I would like to give it a try, if the patient agrees. Any other doctors have any other ideas or comments? BTW, I also like the AGPH HIV drug pipeline. Best regards, "IZZY"
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext